Skip to content

Insider · CIK 0001718621

M33 Growth I L.P.

directorowner

Files at STLN (Oncology Institute, Inc.). First filing May 22, 2025, latest Sep 5, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $28M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

STLN: Oncology Institute, Inc.

STLNOct 9, 2026 · close 6.63

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
50Moderate
STLNsell
Oncology Institute, Inc.
$21M
6,700,000 shares
-48%+2370% from low-24% from high
48Moderate
STLNsell 2
Oncology Institute, Inc.
$2.3M
750,000 shares
-5%+2014% from low-16% from high
53Moderate
STLNsell 2
Oncology Institute, Inc.
$5.4M
2,000,000 shares
-12%+2006% from low-16% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 18, 2025STLN
Oncology Institute, Inc.
JOther
Common Stockindirect: See Footnote
-590,892--0Nov 20, 2025
Nov 18, 2025STLN
Oncology Institute, Inc.
JOther
Common Stock
+11,818--7,944,207Nov 20, 2025
Nov 18, 2025STLN
Oncology Institute, Inc.
JOther
Common Stock
-2,500,000--5,444,207Nov 20, 2025
Sep 4, 2025STLN
Oncology Institute, Inc.
SOpen-market sale
Common Stock
-6,018,168$3.09$19M7,932,389Sep 5, 2025
Sep 4, 2025STLN
Oncology Institute, Inc.
SOpen-market sale
Common Stockindirect: See Footnote
-681,832$3.09$2.1M590,892Sep 5, 2025
Jun 5, 2025STLN
Oncology Institute, Inc.
SOpen-market sale
Common Stock
-673,676$3.05$2.1M13,950,557Jun 9, 2025
Jun 5, 2025STLN
Oncology Institute, Inc.
SOpen-market sale
Common Stockindirect: See Footnote
-76,324$3.05$233k1,272,724Jun 9, 2025
May 20, 2025STLN
Oncology Institute, Inc.
SOpen-market sale
Common Stock
-1,796,468$2.71$4.9M14,624,233May 22, 2025
May 20, 2025STLN
Oncology Institute, Inc.
SOpen-market sale
Common Stockindirect: See Footnote
-203,532$2.71$552k1,349,048May 22, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

M33 Growth I L.P.: insider trades and track record | InsiderTell